Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Medtronic plc (MDT)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
106.87-0.41 (-0.38%)
At close: 04:00PM EST
106.96 +0.09 (+0.08%)
After hours: 07:03PM EST
Advertisement
Sign in to post a message.
  • A
    Anonymous
    undervalued at these levels. I am buying down to $100. If 100 is breached I am taking out long calls. This company is solid. Beat up too badly.
  • L
    LA
    Needham lowered price target to $145 based on ER. MDT beat estimates but missed revenues based on analyst expectations. Miss was minimal and its a BUY BUY BUY here
  • a
    aabb
    MDT + ALPP Rising 800 % and AABB crypto stock Rising 4,000 % in 2021.
    Bullish
  • L
    LA
    MDT is way OVERSOLD. Time to buy folks
  • N
    Nao
    MDT had revenue headwinds due to hospitals differing many medical procedures during covid. As covid is lifing the pent up demand for needed med procedures should reflect in coming quarter(s) revenues. Im losding up.
  • K
    Km
    let's go
    Bullish
  • B
    Bill mddb
    I guess that the news today about J&J breaking up into drugs & medical devices in one company and consumer product in the other has been pressuring stocks like MDT , Stryker et. al. -- the drugs and medical devices company will have about $80 bil of revenue, more than double MDT. I also think $32 bil of revenue is enough for MDT to fund all the R&D it can invest effectively. So I don't see this as a big negative because MDT has been competing against JNJ all along. So when JNJ broken up into two stocks in 18-24 months I do not see how that is a much bigger threat then they are now. A part of the motivation to split into two has to be to contain all the baby powder & other consumer lawsuits.
  • b
    bill
    Jon Nagarian on CNBC said massive calls being bought (Jan 125s). Said to plan on heading to $130 in the next 2 months. Check it out.
  • B
    Bill mddb
    No doubt the Covid situation in Germany and other hot spots has dampened the outlook for elective procedures. The Delta variant here seemed to come & go, and was probably overblown in the press. Also no doubt that MDT's outlook will be key to how the market reacts to Q2 earnings.
  • P
    P
    ABT still taking new investors. MDT is dead money until the virus is gone. And who knows when that will be.
  • L
    LA
    Bottom is in folks! Ride it back to $140
  • B
    Bill mddb
    It looks to be a tuff day for medical device stocks given that Stryker is indicated to open down 2% - 3% in reaction to their earnings report after the bell last night. I'm prepared to buy on a swoon. I already have a big % of my retirement account and portfolio account in MDT plc, as well as having about 25% cash at this point. If the market tanks and MDT dips enough I would add. I do expect to see a good earnings report and outlook. A wild card would be the impact, if any, and if material on MDT inventory conversion due to chip shortages. I remember well the Diabetes division woes when it suddenly, way before expected, an approved "G" device - could have been the 740G -- the first with an advanced technology to keep Type 1 in range based on MDT's feedback loop. They could manufacture the devices but could not source the sensors without building a manufacturing facility to produce them which delayed the new device & tech by 6-9 months. The Diabetes segment hasn't been able to catch up since then. Hopefully the new 780G unit parts will not be filling up storage space waiting for chips. MDT is in a different space than AAPL which just missed on Rev & EPS - $6 bil of revenue deferred due to chip shortages they said. Hopefully the G sensor capacity lesson prompted Omar to have key MDT supply chains subject to on-going analysis and review. Good Luck...
  • R
    Rob
    Great buying opportunity premarket
    Bullish
  • b
    bigboss
    (BEAT) $4..MC $31 m..Blockbuster product NEAR approval / NEW nasdaq stock =1000%+ UPSIDE !!

    "HeartBeam developed a mHealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ECG and examining the patient. It comprises a credit card size, 12 lead equivalent, ECG device, and a cloud-based diagnostic expert system. Studies designed by Harvard Medical School faculty have shown HeartBeam's performance to be equal or better than world-class cardiologists in diagnosing a heart attack. The technology features personalized diagnostic thresholds and novel heart attack ECG markers from which the application can also help Cardiologists locate a heart attack on a 3D model of the heart. HeartBeam's iCardiologist application utilizes Artificial Intelligence / Machine Learning to drive continuous improvements to the system's ability to provide patient analysis and improve the solution's predictive properties."

    #+#+
  • R
    Rex
    I can’t wait to get this for $114
    Bullish
  • j
    jsUVA
    Very positive news..
    Medtronic (NYSE:MDT) is in advanced talks to acquire Israeli startup Triple Jump for $300M, Calcalist reported on Sunday.
    The U.S medical device maker had already made an investment in Triple Jump in 2015 with an option to acquire it. Founded in 2015, Triple Jump is developing a small insulin pump patch with mobile connectivity.
    A deal is likely to further expand Medtronic’s (MDT) market presence in diabetes care
    Bullish
  • D
    DAVID
    why the big hit today?
  • k
    kram
    Bottomed yet? How would you know?
  • R
    Roman
    Medtronic (NYSE:MDT) has lost ~4.7% in the post-market after a company announcement indicated a potential delay in its clinical program for Symplicity Renal Denervation System.
  • L
    LA
    Price Target CUT by Wellsfargo this morning....thats main reason why it's down.

    "Analysts at Wells Fargo cut their price target on the medical device maker to $144 a share from $151, while maintaining an overweight rating on the stock. Medtronic ( MDT ) has an average investment rating of outperform among analysts polled by Capital IQ, with a price target range of $129 to $155".
Advertisement
Advertisement